<DOC>
	<DOCNO>NCT00424866</DOCNO>
	<brief_summary>FGF-1 treatment patient peripheral arterial disease intermittent claudication .</brief_summary>
	<brief_title>FGF-1 Intramuscular Injection Treatment Peripheral Arterial Disease</brief_title>
	<detailed_description>FGF-1 administer intramuscular injection treatment peripheral arterial disease intermittent claudication . Eligible patient allocate one three treatment arm . Patients within dose group randomize study drug vehicle control . Safety , pharmacokinetics , cardiovascular improvement evaluate day 1 week 1 , 4 12 post dosing .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>Inclusion Criteria 1 . Subjects consider eligible enter study must sign informed consent form prior initiation study procedure . In event subject must withdraw rescreened study participation later date , new inform consent form must sign . Subjects must competent give write informed consent . 2 . Age must ≥50 ≤75 year age life expectancy &gt; 1 year leg survival &gt; 6 month . Patients &gt; 75 ≤80 year age consider show sign cognitive muscle function decline fully able comply protocol . 3 . Patients must experience intermittent claudication least 6 month stable past 3 month . 4 . Patients must peripheral arterial disease , confirm rest ABI ≥0.40 &lt; 0.90 base least one leg measure use dorsal pedis posterior tibial artery . 5 . Stenosis &gt; 70 % total occlusion must present popliteal artery and/or tibial peroneal trunk least 2 tibial artery ankle without inflow limitation popliteal artery . Adequate popliteal inflow define continuous flow abdominal aorta , iliac , common femoral superficial femoral stenosis &lt; 50 % determine either intraarterial DSA , CTA Gd CEMRA . 6 . The screening Gardner treadmill test peak walk time ( PWT ) must &gt; 1 minute &lt; 12 minute limit pain one calve . 7 . Preexisting medication regime must stable 6 week precede dose . Exclusion Criteria 1 . Evidence critical leg ischemia , i.e . ischemic rest pain ischemic ulceration 2 . Treadmill walk limited condition intermittent claudication include arthritis , angina dyspnea 3 . Lower limb amputation , , either leg include toe 4 . Evidence limb ischemia immunologic inflammatory disorder 5 . Leg surgery revascularization within past 6 month peripheral angioplasty within past 3 month anticipate study 6 . Participation investigational device drug trial within past 6 month 7 . Myocardial infarction , unstable angina , stroke ischemic attack within past 6 month 8 . New York Heart Association ( NYHA ) class II , III IV heart failure , restrictive hypertrophic cardiomyopathy severe valvular disease 9 . QTc elongation great 450 m male 460 m females 10 . PT ( INR ) , PTT , urinalysis , thyroid function ( T3 , T4 , TSH ) outside normal limit 11 . Hemorrhage thrombotic event ( e.g . deep vein thrombosis ) within past 6 month 12 . Thrombocytopenia ( &lt; 100,000/µl ) , history heparininduced thrombocytopenia 13 . Major surgery past 6 month 14 . Positive proliferative retinopathy exam 15 . Present type cancer history cancer except past ( present ) basal cell dermal carcinoma either leg 16 . Inflammatory progressive fibrotic myelofibrotic disorder 17 . Patients experience bacterial viral infection ( e.g . hepatitis HIV ) may otherwise febrile 18 . Hemoglobin A1c ( HgbA1c ) &gt; 8 % 19 . Type I diabetes 20 . Total fast cholesterol &gt; 200 21 . Uncontrolled hypertension ( ≥160 systolic ≥100 diastolic pressure ) hypotension ( &lt; 90 systolic &lt; 60 diastolic pressure ) 22 . Disease drug ( e.g . systemic corticosteroid ) immunocompromised 23 . Hepatic dysfunction define either AST ALT &gt; 2.0 time upper limit normal 24 . Serum creatinine ≥ 2.5 mg/dl 25 . Proteinuria ( urine protein/creatinine ratio &gt; 3 ) 26 . Antiproliferative drug ( e.g . thalidomide , hydroxyurea ) 27 . Radiation therapy 28 . Implanted device compatible strong magnetic field 29 . Life expectance less 1 year 30 . Females premenopausal sterilize use adequate birth control either pregnant , intend become pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Peripheral Arterial Disease</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Intermittent Claudication</keyword>
</DOC>